| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Clopidogrel | FAERS: 4 | US FAERS | |
| 2 | Sunitinib | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 3 | Dabigatran | FAERS: 2 | US FAERS | |
| 4 | Polidocanol | FAERS: 2 | US FAERS | |
| 5 | Teriparatide | FAERS: 2 | US FAERS | |
| 6 | 4-Aminopyridine | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | Ethinyl Estradiol-Norgestrel Combination | FAERS: 1 | US FAERS | |
| 8 | Lapatinib | FAERS: 1 | US FAERS | |
| 9 | Letrozole | FAERS: 1 | US FAERS | |
| 10 | Norgestrel | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | NuvaRing | FAERS: 1 | US FAERS | |
| 12 | Testosterone | FAERS: 1 | US FAERS | |
| 13 | Tinzaparin | FAERS: 1 | US FAERS | |
| 14 | Norethindrone Acetate | Canada Vigilance: 1 | Canada Vigilance | |
| 15 | Ovosiston | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.